Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Acceleron
Pharma
Merck touts newly approved Winrevair as example of BD acumen
Merck touted newly approved Winrevair and what the emergence of the potential blockbuster means for the company as it faces the Keytruda LOE.
Kevin Dunleavy
Apr 25, 2024 11:06am
FDA signs off on Merck’s potential blockbuster Winrevair for PAH
Mar 26, 2024 5:11pm
Even after Prometheus, Acceleron deals, Merck primed for M&A
Feb 1, 2024 11:01am
After recent moves, Merck no longer focused on Keytruda deadline
Apr 27, 2023 1:22pm
Merck CEO Davis touts potential of CV drug candidates
Oct 27, 2022 12:02pm
'The Top Line': The most productive pharmas, Biogen's leadership
Oct 14, 2022 6:00am
